Resonant Capital Advisors LLC Lowers Stock Holdings in The Procter & Gamble Company (NYSE:PG)

Resonant Capital Advisors LLC lowered its position in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 2.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 20,338 shares of the company’s stock after selling 567 shares during the period. Resonant Capital Advisors LLC’s holdings in Procter & Gamble were worth $2,980,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Emerald Advisors LLC increased its stake in Procter & Gamble by 1.8% during the 4th quarter. Emerald Advisors LLC now owns 3,775 shares of the company’s stock valued at $553,000 after purchasing an additional 65 shares in the last quarter. O Brien Wealth Partners LLC lifted its position in Procter & Gamble by 3.3% during the 4th quarter. O Brien Wealth Partners LLC now owns 2,062 shares of the company’s stock worth $302,000 after acquiring an additional 65 shares during the period. KFA Private Wealth Group LLC grew its stake in Procter & Gamble by 2.2% during the 3rd quarter. KFA Private Wealth Group LLC now owns 3,054 shares of the company’s stock valued at $445,000 after purchasing an additional 67 shares during the last quarter. Chemistry Wealth Management LLC increased its holdings in shares of Procter & Gamble by 1.2% in the fourth quarter. Chemistry Wealth Management LLC now owns 5,839 shares of the company’s stock valued at $856,000 after purchasing an additional 67 shares during the period. Finally, Schear Investment Advisers LLC raised its stake in shares of Procter & Gamble by 1.4% in the fourth quarter. Schear Investment Advisers LLC now owns 4,933 shares of the company’s stock worth $723,000 after purchasing an additional 67 shares during the last quarter. Institutional investors own 65.77% of the company’s stock.

Wall Street Analyst Weigh In

PG has been the topic of a number of recent research reports. JPMorgan Chase & Co. lowered their target price on Procter & Gamble from $169.00 to $162.00 and set an “overweight” rating on the stock in a research note on Thursday, January 18th. UBS Group boosted their target price on shares of Procter & Gamble from $172.00 to $178.00 and gave the company a “buy” rating in a research note on Wednesday, January 24th. Wells Fargo & Company raised their price target on shares of Procter & Gamble from $162.00 to $170.00 and gave the company an “overweight” rating in a research report on Wednesday, January 24th. Barclays increased their target price on shares of Procter & Gamble from $165.00 to $168.00 and gave the stock an “overweight” rating in a research note on Friday, April 12th. Finally, Truist Financial raised Procter & Gamble from a “hold” rating to a “buy” rating and upped their price target for the stock from $160.00 to $175.00 in a report on Monday, March 11th. Seven research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $168.53.

Get Our Latest Research Report on Procter & Gamble

Procter & Gamble Price Performance

PG stock traded up $0.32 during midday trading on Friday, reaching $157.61. The stock had a trading volume of 8,199,520 shares, compared to its average volume of 6,878,836. The Procter & Gamble Company has a 52-week low of $141.45 and a 52-week high of $163.14. The company has a market cap of $370.86 billion, a price-to-earnings ratio of 26.31, a price-to-earnings-growth ratio of 3.21 and a beta of 0.44. The company’s fifty day simple moving average is $159.13 and its 200 day simple moving average is $152.83. The company has a current ratio of 0.64, a quick ratio of 0.44 and a debt-to-equity ratio of 0.48.

Procter & Gamble (NYSE:PGGet Free Report) last posted its quarterly earnings results on Friday, April 19th. The company reported $1.52 earnings per share for the quarter, topping the consensus estimate of $1.42 by $0.10. The firm had revenue of $20.20 billion for the quarter, compared to the consensus estimate of $20.43 billion. Procter & Gamble had a net margin of 17.60% and a return on equity of 34.04%. The company’s revenue for the quarter was up .6% on a year-over-year basis. During the same period last year, the firm posted $1.37 earnings per share. As a group, sell-side analysts predict that The Procter & Gamble Company will post 6.45 earnings per share for the current fiscal year.

Procter & Gamble Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be given a dividend of $1.0065 per share. This is an increase from Procter & Gamble’s previous quarterly dividend of $0.94. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $4.03 dividend on an annualized basis and a yield of 2.55%. Procter & Gamble’s dividend payout ratio (DPR) is presently 67.34%.

Insiders Place Their Bets

In other Procter & Gamble news, insider Marc S. Pritchard sold 101,704 shares of Procter & Gamble stock in a transaction dated Wednesday, January 24th. The shares were sold at an average price of $153.57, for a total transaction of $15,618,683.28. Following the transaction, the insider now directly owns 163,428 shares of the company’s stock, valued at $25,097,637.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, insider Marc S. Pritchard sold 101,704 shares of the stock in a transaction on Wednesday, January 24th. The stock was sold at an average price of $153.57, for a total transaction of $15,618,683.28. Following the completion of the transaction, the insider now directly owns 163,428 shares in the company, valued at approximately $25,097,637.96. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Susan Street Whaley sold 3,865 shares of the business’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $160.60, for a total transaction of $620,719.00. Following the completion of the sale, the insider now owns 11,886 shares in the company, valued at $1,908,891.60. The disclosure for this sale can be found here. Insiders sold 279,063 shares of company stock valued at $43,187,745 in the last three months. 0.17% of the stock is currently owned by insiders.

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Further Reading

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.